[{"accession_id":"EGAD50000000902","title":"Arcagen - Sarcoma","description":"Arcagen is an EORTC/SPECTA pan-European project that aims to recruit 1000 rare cancer patients from different tumour domains of EURACAN. This study collected samples from advanced or metastatic rare cancer from patients older than 12, and analysed them using Foundation Medicine next-generation sequencing (NGS) panels (FoundationOne CDx for FFPE samples or FoundationOne Liquid CDx for blood samples). Here we are submitting the dataset that contain NGS files in .BAM format from 62 patients with undifferentiated sarcoma of the bone; aggressive angiomyxoma; alveolar soft part sarcoma; small round cell sarcoma without EWSR1 and CIC translocations; undifferentiated pleomorphic sarcoma; undifferentiated sarcoma; myxofibrosarcoma; or sarcoma with an incidence of less than 1 per 10 million.","dataset_types":["Exome sequencing"],"technologies":["Illumina HiSeq 4000"],"num_samples":62,"access_type":"controlled","is_in_beacon":false,"is_released":true,"released_date":"2026-07-02T14:12:18.870192+02:00","is_deprecated":false,"policy_accession_id":"EGAP00001001798"}]